Multi-center study finds postoperative residual non-enhancing component of glioblastoma as a new determinant of patient outcome.
Aikaterini KotrotsouAhmed ElakkadJia SunGinu A ThomasDongni YangSrishti AbrolWei WeiJeffrey S WeinbergAli S BakhtiariMoritz F KircherMarkus M LuediJohn F de GrootRaymond SawayaAshok J KumarPascal O ZinnRivka R ColenPublished in: Journal of neuro-oncology (2018)
Our results demonstrate that high PRNV is associated with poor OS. Such results could be of great importance in a clinical setting, particularly in the postoperative management and monitoring of therapy.